Santhera anuncia hoy la ampliaci\u00f3n de su acuerdo de distribuci\u00f3n exclusiva con Biomedica para AGAMREE (vamorolona), extendiendo la colaboraci\u00f3n a Georgia, Kazajst\u00e1n, Bielorrusia, Azerbaiy\u00e1n y Uzbekist\u00e1n, para el tratamiento de la distrofia muscular de Duchenne (DMD) en pacientes de dos a\u00f1os de edad o mayores.<\/p>\n\n\n\n
Biomedica fue designado distribuidor de AGAMREE\u00ae en octubre de 2025. Seg\u00fan el acuerdo ampliado, Biomedica ser\u00e1 responsable de la distribuci\u00f3n en los cinco mercados adicionales, mientras que Santhera seguir\u00e1 recibiendo un porcentaje de las ventas netas conforme a los t\u00e9rminos del acuerdo original. Aproximadamente 2000 pacientes viven con distrofia muscular de Duchenne (DMD) en estos pa\u00edses adicionales, donde hist\u00f3ricamente las opciones de tratamiento se han limitado en gran medida a los corticosteroides est\u00e1ndar. El acuerdo ampliado abre la puerta a que AGAMREE\u00ae est\u00e9 disponible para estos pacientes. Leer m\u00e1s: \u00bfQu\u00e9 es AGAMREE (Vamorolone)?<\/a><\/p>\n\n\n\n <\/p>","protected":false},"excerpt":{"rendered":" Santhera today announces an expansion of its exclusive distribution agreement with Biomedica for AGAMREE (vamorolone), extending the partnership to include Georgia, Kazakhstan, Belarus, Azerbaijan and Uzbekistan, for the treatment of Duchenne muscular dystrophy (DMD) in patients two years of age and older. Biomedica was originally appointed as a distributor for AGAMREE\u00ae in October 2025. Under […]<\/p>\n","protected":false},"author":1,"featured_media":8252,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[42,846,845,433,843,844,41,43],"class_list":["post-8251","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-agamree","tag-azerbaijan","tag-belarus","tag-biomedica","tag-georgia","tag-kazakhstan","tag-santhera","tag-vamorolone"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts\/8251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/comments?post=8251"}],"version-history":[{"count":1,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts\/8251\/revisions"}],"predecessor-version":[{"id":8253,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/posts\/8251\/revisions\/8253"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/media\/8252"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/media?parent=8251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/categories?post=8251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/es\/wp-json\/wp\/v2\/tags?post=8251"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}